首页 > 最新文献

中华老年医学杂志最新文献

英文 中文
Key points for the prevention and treatment of the novel coronavirus pneumonia in the elderly 老年人新型冠状病毒肺炎防治要点
Pub Date : 2020-02-20 DOI: 10.3760/CMA.J.ISSN.0254-9026.2020.02.001
Qiong Chen, Weiwei Yu, Lijing Wang, H. Xi, Qiang Zhang, Xinyu Chen, Kui Huang, Xiang Lu, Xinmin Liu, Cun-yuan Zhang, Jianye Wang
The population is commonly susceptible to the 2019 novel coronavirus(2019-nCoV), especially the elderly with comorbidities. Elderly patients infected with 2019-nCoV tend to have higher rates of severe illnesses and mortality. Immunoaging is an important cause of severe novel coronavirus pneumonia(NCP)in the elderly.Due to the combination of underlying diseases, elderly patients may exhibit a typical manifestations in clinical symptoms, supplementary examinations and pulmonary imaging, deserving particular attention. The general condition of the elderly should be considered during diagnosis and treatment. In addition to routine care and measures such as oxygen therapy, antiviral therapy and respiratory support, treatment of underlying disease, nutritional support, sputum expectoration, complication prevention and psychological support should also be considered for elderly patients. Based on literature review and expert panel discussion, we drafted the Key Points for the Prevention and Treatment of the Novel Coronavirus Pneumonia in the elderly, aiming to provide help with the prevention and treatment of NCP and the reduction of harm to the elderly population. Key words: 2019 Novel coronavirus(2019-nCoV); Pneumonia; Prevention and treatment; The elderly
人群普遍易感染2019年新型冠状病毒(2019- ncov),特别是有合并症的老年人。感染新型冠状病毒的老年患者患重症和死亡率往往更高。免疫老化是老年人感染新型冠状病毒感染的重要原因。由于基础疾病的合并,老年患者在临床症状、辅助检查和肺部影像学上可能表现出典型的表现,值得特别关注。在诊断和治疗时应考虑老年人的一般情况。老年患者除氧疗、抗病毒治疗、呼吸支持等常规护理和措施外,还应考虑基础疾病治疗、营养支持、痰液祛痰、并发症预防和心理支持。在文献查阅和专家小组讨论的基础上,我们起草了《老年人新型冠状病毒感染的肺炎防治要点》,旨在为新型冠状病毒感染的防治提供帮助,减少对老年人的危害。关键词:新型冠状病毒(2019- ncov);肺炎;预防和治疗;老年人
{"title":"Key points for the prevention and treatment of the novel coronavirus pneumonia in the elderly","authors":"Qiong Chen, Weiwei Yu, Lijing Wang, H. Xi, Qiang Zhang, Xinyu Chen, Kui Huang, Xiang Lu, Xinmin Liu, Cun-yuan Zhang, Jianye Wang","doi":"10.3760/CMA.J.ISSN.0254-9026.2020.02.001","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2020.02.001","url":null,"abstract":"The population is commonly susceptible to the 2019 novel coronavirus(2019-nCoV), especially the elderly with comorbidities. Elderly patients infected with 2019-nCoV tend to have higher rates of severe illnesses and mortality. Immunoaging is an important cause of severe novel coronavirus pneumonia(NCP)in the elderly.Due to the combination of underlying diseases, elderly patients may exhibit a typical manifestations in clinical symptoms, supplementary examinations and pulmonary imaging, deserving particular attention. The general condition of the elderly should be considered during diagnosis and treatment. In addition to routine care and measures such as oxygen therapy, antiviral therapy and respiratory support, treatment of underlying disease, nutritional support, sputum expectoration, complication prevention and psychological support should also be considered for elderly patients. Based on literature review and expert panel discussion, we drafted the Key Points for the Prevention and Treatment of the Novel Coronavirus Pneumonia in the elderly, aiming to provide help with the prevention and treatment of NCP and the reduction of harm to the elderly population. \u0000 \u0000 \u0000Key words: \u00002019 Novel coronavirus(2019-nCoV); Pneumonia; Prevention and treatment; The elderly","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"39 1","pages":"113-118"},"PeriodicalIF":0.0,"publicationDate":"2020-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41834183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Recent advances in the physical rehabilitation and reconstruction of coronary microcirculation 冠状动脉微循环的物理康复与重建研究进展
Pub Date : 2020-01-14 DOI: 10.3760/CMA.J.ISSN.0254-9026.2020.01.003
Shao-hua Zhao
冠状动脉(冠脉)微循环障碍在心绞痛患者中普遍存在,相对于传统的心外膜冠脉血运重建,冠脉微循环血运重建对改善心绞痛患者的症状和预后同样重要。体外心脏震波、增强型体外反搏和远隔缺血预适应等物理康复疗法具有多靶点、多通路作用的优势,可通过改善血管内皮和平滑肌功能,促使冠脉侧支循环形成和毛细血管床开放,为冠脉微循环血运重建开辟了新的路径。
冠状动脉(冠脉)微循环障碍在心绞痛患者中普遍存在,相对于传统的心外膜冠脉血运重建,冠脉微循环血运重建对改善心绞痛患者的症状和预后同样重要。体外心脏震波、增强型体外反搏和远隔缺血预适应等物理康复疗法具有多靶点、多通路作用的优势,可通过改善血管内皮和平滑肌功能,促使冠脉侧支循环形成和毛细血管床开放,为冠脉微循环血运重建开辟了新的路径。
{"title":"Recent advances in the physical rehabilitation and reconstruction of coronary microcirculation","authors":"Shao-hua Zhao","doi":"10.3760/CMA.J.ISSN.0254-9026.2020.01.003","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2020.01.003","url":null,"abstract":"冠状动脉(冠脉)微循环障碍在心绞痛患者中普遍存在,相对于传统的心外膜冠脉血运重建,冠脉微循环血运重建对改善心绞痛患者的症状和预后同样重要。体外心脏震波、增强型体外反搏和远隔缺血预适应等物理康复疗法具有多靶点、多通路作用的优势,可通过改善血管内皮和平滑肌功能,促使冠脉侧支循环形成和毛细血管床开放,为冠脉微循环血运重建开辟了新的路径。","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"39 1","pages":"20-22"},"PeriodicalIF":0.0,"publicationDate":"2020-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45271601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation on the current status of recognition and acceptance of living will in elderly inpatients in Shanxi Province 山西省老年住院患者生活意愿认知与接受现状调查
Pub Date : 2020-01-14 DOI: 10.3760/CMA.J.ISSN.0254-9026.2020.01.016
Zhao Nan, Yufeng Du
Objective To analyze related factors for whether or not to make the living will by investigating the current status of recognition and acceptance of living will among elderly inpatients in Shanxi Province, in order to provide the evidence for promoting the living will in elderly hospitalized patients in Shanxi Province. Methods A questionnaire survey was conducted on elderly inpatients in Shanxi Province from January 2017 to December 2017, including general information(age, gender, ethnicity, religious belief, dwelling place, education and profession, children, spouse), awareness of living wills and willingness to sign documents of "My Five Wishes" . The chi-square test and Logistic regression analysis were used to analyze the related factors for elderly inpatients' willingness to sign living will documents Results The 411 elderly inpatients in Shanxi Province had a low level of cognition of living will(146 cases, 35.5%). In general socio-demographic characteristics, only education level and profession were related to the cognition of living will(χ2=12.093 and 11.906, P=0.001 and 0.008). Multivariate Logistic regression analysis showed that as compared with inpatients aged 60-69 years, inpatients aged 70-79 years(OR=0.592, 95%CI: 0.360~0.974, P=0.039)and 80-89 years(OR=0.408, 95%CI: 0.238~0.701, P=0.001)held a significantly negative attitude towards signing the living will documents.According to dwelling place, as compared with countryside, urban elderly inpatients were more willing to sign living will documents in advance(OR=2.293, 95%CI: 1.335~3.940, P=0.003). At the comparison of other occupations with medical workers, teachers(P=0.429), civil servants(P=0.068), only medical workers(OR=3.156, 95%CI: 1.419-7.020, P=0.005)were more willing to sign living will documents in advance.As comparing elderly inpatients with children, the childless elderly inpatients were more willing to sign living will documents in advance(OR=3.156, 95%CI: 1.287~7.740, P=0.012). Conclusions Elderly inpatients in Shanxi Province have a low level of cognition of living will and a poor acceptance of signing the document of "my five wishes" in advance.In order to benefit the public, we need to increase the promotion and popularization of signing documents of living will in our province. Key words: Living will; Informed consent; Medical autonomy
目的通过调查山西省老年住院患者对生前遗嘱的认知和接受现状,分析是否立生前遗嘱的相关因素,为促进山西省老年住院患者立生前遗嘱提供依据。方法对2017年1月至2017年12月山西省老年住院患者进行问卷调查,包括一般信息(年龄、性别、民族、宗教信仰、居住地、学历及职业、子女、配偶)、生前遗嘱意识、“我的五个愿望”签署意愿等。采用卡方检验和Logistic回归分析分析老年住院患者生前遗嘱签署意愿的相关因素。结果山西省411例老年住院患者对生前遗嘱的认知水平较低(146例,占35.5%)。在一般社会人口学特征中,只有受教育程度和职业与生活意愿认知相关(χ2=12.093和11.906,P=0.001和0.008)。多因素Logistic回归分析显示,与60~ 69岁住院患者相比,70 ~ 79岁住院患者(OR=0.592, 95%CI: 0.360~0.974, P=0.039)和80 ~ 89岁住院患者(OR=0.408, 95%CI: 0.238~0.701, P=0.001)对签署生前遗嘱文件持显著消极态度。按居住地划分,城市住院老年患者较农村住院老年患者更愿意提前签署生前遗嘱文件(OR=2.293, 95%CI: 1.335~3.940, P=0.003)。与医务工作者相比,教师(P=0.429)、公务员(P=0.068),只有医务工作者(OR=3.156, 95%CI: 1.419-7.020, P=0.005)更愿意提前签署生前遗嘱文件。与有子女的老年住院患者相比,无子女的老年住院患者更愿意提前签署生前遗嘱(OR=3.156, 95%CI: 1.287~7.740, P=0.012)。结论山西省老年住院患者对生前遗嘱的认知水平较低,对提前签署“我的五个愿望”文件的接受程度较差。为了造福大众,我们需要加大生前遗嘱签署工作在我省的推广和普及力度。关键词:生前遗嘱;知情同意;医疗自主权
{"title":"Investigation on the current status of recognition and acceptance of living will in elderly inpatients in Shanxi Province","authors":"Zhao Nan, Yufeng Du","doi":"10.3760/CMA.J.ISSN.0254-9026.2020.01.016","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2020.01.016","url":null,"abstract":"Objective \u0000To analyze related factors for whether or not to make the living will by investigating the current status of recognition and acceptance of living will among elderly inpatients in Shanxi Province, in order to provide the evidence for promoting the living will in elderly hospitalized patients in Shanxi Province. \u0000 \u0000 \u0000Methods \u0000A questionnaire survey was conducted on elderly inpatients in Shanxi Province from January 2017 to December 2017, including general information(age, gender, ethnicity, religious belief, dwelling place, education and profession, children, spouse), awareness of living wills and willingness to sign documents of \"My Five Wishes\" . The chi-square test and Logistic regression analysis were used to analyze the related factors for elderly inpatients' willingness to sign living will documents \u0000 \u0000 \u0000Results \u0000The 411 elderly inpatients in Shanxi Province had a low level of cognition of living will(146 cases, 35.5%). In general socio-demographic characteristics, only education level and profession were related to the cognition of living will(χ2=12.093 and 11.906, P=0.001 and 0.008). Multivariate Logistic regression analysis showed that as compared with inpatients aged 60-69 years, inpatients aged 70-79 years(OR=0.592, 95%CI: 0.360~0.974, P=0.039)and 80-89 years(OR=0.408, 95%CI: 0.238~0.701, P=0.001)held a significantly negative attitude towards signing the living will documents.According to dwelling place, as compared with countryside, urban elderly inpatients were more willing to sign living will documents in advance(OR=2.293, 95%CI: 1.335~3.940, P=0.003). At the comparison of other occupations with medical workers, teachers(P=0.429), civil servants(P=0.068), only medical workers(OR=3.156, 95%CI: 1.419-7.020, P=0.005)were more willing to sign living will documents in advance.As comparing elderly inpatients with children, the childless elderly inpatients were more willing to sign living will documents in advance(OR=3.156, 95%CI: 1.287~7.740, P=0.012). \u0000 \u0000 \u0000Conclusions \u0000Elderly inpatients in Shanxi Province have a low level of cognition of living will and a poor acceptance of signing the document of \"my five wishes\" in advance.In order to benefit the public, we need to increase the promotion and popularization of signing documents of living will in our province. \u0000 \u0000 \u0000Key words: \u0000Living will; Informed consent; Medical autonomy","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"39 1","pages":"83-88"},"PeriodicalIF":0.0,"publicationDate":"2020-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69870400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The evaluation of cognitive impairment and analysis of risk factors for stroke recurrence in elderly patients with minor ischemic stroke 老年轻度缺血性脑卒中患者认知功能障碍评价及卒中复发危险因素分析
Pub Date : 2020-01-14 DOI: 10.3760/CMA.J.ISSN.0254-9026.2020.01.004
Xinqiang Wang, Bin Li, Xiaojing Wang, Yuezhen Shen, Yanfei Chen
Objective To evaluate the cognitive impairment in elderly patients with minor ischemic stroke and to analyze risk factors for stroke recurrence. Methods This was a retrospective case-control study.Ninety-five elderly patients with acute ischemic stroke hospitalized in the neurology department of Second People's Hospital of Liaocheng were enrolled from January 2016 to January 2017.Based on the National Institutes of Health Stroke Scale(NIHSS), all cases were divided into the minor stroke group(NIHSS score≤3, n=62)and the medium-severe stroke group(NIHSS score>3, n=33). After 12-month follow-up, the NIHSS, modified Rankin scale(mRS)and Montreal cognitive assessment(MoCA)were used to evaluate the study subjects. Results Of the 95 patients, there were 62 males(65.3%)and 33 females(34.7%), with age of(68.3±6.7)years.No significant differences were found in baseline characteristics of age, male ratio, subtypes and history between two groups(all P>0.05). But, the treatment rate of intravenous thrombolysis was lower in minor stroke group than in medium-severe stroke group[6.5%(4 cases)vs.42.4%(14 cases)(P 0.05), while the rate of post stroke depression had a significant difference between two groups(P<0.05). Furthermore, there was lower rate of mortality and stroke recurrence in the minor stroke group than in the medium-severe group(0.0% or 0/62 vs.30.3% or 10/33, and 21.0% or 13/62 vs.42.4% or 14/33, P<0.05). Cox proportional hazard model showed that baseline NIHSS score, diabetes and stroke history were the risk factors for stroke recurrence in patients with minor stroke(P<0.05). Conclusions The treatment rate of intravenous thrombolysis with rt-PA, mortality rate and stroke recurrence rate are lower in patients with minor stroke than in patients with medium-severe stroke, while the incidence of post stroke cognitive impairment is high.High score of baseline NIHSS, diabetes and stroke history are risk factors for stroke recurrence in elderly patients with minor stroke. Key words: Brain ischemic; Stroke; Cognitive impairment; Risk factor
目的评价老年轻度缺血性脑卒中患者的认知功能障碍,分析卒中复发的危险因素。方法采用回顾性病例对照研究。选取2016年1月至2017年1月在聊城市第二人民医院神经内科住院的老年急性缺血性脑卒中患者95例。根据美国国立卫生研究院卒中量表(NIHSS)将所有病例分为轻度卒中组(NIHSS评分≤3分,n=62)和中重度卒中组(NIHSS评分>.3分,n=33)。随访12个月后,采用NIHSS、改良Rankin量表(mRS)和Montreal认知评估(MoCA)对研究对象进行评估。结果95例患者中,男性62例(65.3%),女性33例(34.7%),年龄(68.3±6.7)岁。两组患者的年龄、男性比例、亚型及病史等基线特征均无统计学差异(P < 0.05)。轻度脑卒中组静脉溶栓治愈率低于中重度脑卒中组[6.5%(4例)比42.4%(14例)](P 0.05),两组脑卒中后抑郁率差异有统计学意义(P<0.05)。轻度卒中组病死率和卒中复发率均低于中重度卒中组(0.0%或0/62比30.3%或10/33,21.0%或13/62比42.4%或14/33,P<0.05)。Cox比例风险模型显示,基线NIHSS评分、糖尿病和卒中史是轻度卒中患者卒中复发的危险因素(P<0.05)。结论轻度脑卒中患者静脉溶栓rt-PA的治愈率、病死率、卒中复发率均低于中重度脑卒中患者,卒中后认知功能障碍发生率较高。基线NIHSS高分、糖尿病和卒中史是老年轻度卒中患者卒中复发的危险因素。关键词:脑缺血;中风;认知障碍;风险因素
{"title":"The evaluation of cognitive impairment and analysis of risk factors for stroke recurrence in elderly patients with minor ischemic stroke","authors":"Xinqiang Wang, Bin Li, Xiaojing Wang, Yuezhen Shen, Yanfei Chen","doi":"10.3760/CMA.J.ISSN.0254-9026.2020.01.004","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2020.01.004","url":null,"abstract":"Objective \u0000To evaluate the cognitive impairment in elderly patients with minor ischemic stroke and to analyze risk factors for stroke recurrence. \u0000 \u0000 \u0000Methods \u0000This was a retrospective case-control study.Ninety-five elderly patients with acute ischemic stroke hospitalized in the neurology department of Second People's Hospital of Liaocheng were enrolled from January 2016 to January 2017.Based on the National Institutes of Health Stroke Scale(NIHSS), all cases were divided into the minor stroke group(NIHSS score≤3, n=62)and the medium-severe stroke group(NIHSS score>3, n=33). After 12-month follow-up, the NIHSS, modified Rankin scale(mRS)and Montreal cognitive assessment(MoCA)were used to evaluate the study subjects. \u0000 \u0000 \u0000Results \u0000Of the 95 patients, there were 62 males(65.3%)and 33 females(34.7%), with age of(68.3±6.7)years.No significant differences were found in baseline characteristics of age, male ratio, subtypes and history between two groups(all P>0.05). But, the treatment rate of intravenous thrombolysis was lower in minor stroke group than in medium-severe stroke group[6.5%(4 cases)vs.42.4%(14 cases)(P 0.05), while the rate of post stroke depression had a significant difference between two groups(P<0.05). Furthermore, there was lower rate of mortality and stroke recurrence in the minor stroke group than in the medium-severe group(0.0% or 0/62 vs.30.3% or 10/33, and 21.0% or 13/62 vs.42.4% or 14/33, P<0.05). Cox proportional hazard model showed that baseline NIHSS score, diabetes and stroke history were the risk factors for stroke recurrence in patients with minor stroke(P<0.05). \u0000 \u0000 \u0000Conclusions \u0000The treatment rate of intravenous thrombolysis with rt-PA, mortality rate and stroke recurrence rate are lower in patients with minor stroke than in patients with medium-severe stroke, while the incidence of post stroke cognitive impairment is high.High score of baseline NIHSS, diabetes and stroke history are risk factors for stroke recurrence in elderly patients with minor stroke. \u0000 \u0000 \u0000Key words: \u0000Brain ischemic; Stroke; Cognitive impairment; Risk factor","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"39 1","pages":"23-26"},"PeriodicalIF":0.0,"publicationDate":"2020-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46572905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of difference in oral bacteria flora in saliva among elderly people in longevity zone of Guangxi 广西长寿区老年人唾液口腔菌群差异分析
Pub Date : 2020-01-14 DOI: 10.3760/CMA.J.ISSN.0254-9026.2020.01.015
Yan-Chun Qin, Yan-Qiang Huang, H. Tang, Gan-rong Huang, Hong-Yu Wei, Zhenfeng Xie, Gang Lu
Objective To investigate the bacterial species, characteristics and differences of oral bacteria flora of saliva in the longevous elderly between in Bama county and in Debao county in Guangxi, in order to explore the relationship between longevity and oral salivary bacteria flora in the elderly. Methods The saliva was taken from the longevous elderly in Bama county(BM group)and people aged over 60 years in Debao county(BS group)separately, and the total DNA was extracted.The 16S rDNA-V4 region was amplified by PCR and analyzed by sequencing.The main species and diversity of bacterial colonies were recorded for difference analysis. Results A total of 14 saliva samples were collected from 7 cases in BM group and 7 cases in BS group.A total of 369 OTUs were generated by cluster analysis of 14 samples.At the genus level, the dominant salivary bacteria flora were Ctinomyces, Capnocytophaga, Chryseobacterium, Fusobacterium, Haemophilus, Lactobacillus, Leptotrichia, Neisseria, Porphyromonas, Prevotella, Rothia, Streptococcus, Veillonella in both BM group and BS group.The OTU PCA analysis showed that some evidence for indeterminate differences was found, but statistically significant differences did not exist in the dominant components of oral flora between the two groups(P>0.05). Also, the same tendency toward the diversity(P>0.05)was presented.Similarly, the species annotation analysis and the heat map showed that there were no significant differences(P>0.05)in oral salivary flora composition between the two groups.Lactobacillu was always the prevailing flora in the Phylume, Class, Order, Family and Genus, but the abundance ratio was different between the two groups as following: Lactobacillus abundance in salivary bacteria flora was higher in BM Group than in the BS group, while Mycoplasma abundance was lower in BM Group than in the BS group(P<0.05). Conclusions The dominant salivary bacteria flora is Lactobacillus in both BM and BS group, while, the abundance of Lactobacillus is higher in the BM group than in the BS group, which indicates that the longevity of population in Bama county may be related to Lactobacillus. Key words: Longevity; Saliva; DNA, bacterial
目的了解广西巴马县和德保县长寿老人口腔唾液菌群的菌种、特征及差异,探讨长寿与老年人口腔唾液菌区系的关系。方法分别采集巴马县长寿老人(BM组)和德保县60岁以上老人(BS组)的唾液,提取总DNA。通过PCR扩增16S rDNA-V4区域,并通过测序进行分析。记录菌落的主要种类和多样性进行差异分析。结果BM组7例,BS组7例共采集唾液14份。通过对14个样本进行聚类分析,共产生369个OTU。在属水平上,BM组和BS组的优势唾液菌群均为Ctinomyces、Capnocytophaga、Chrysobacterium、Fusobacterum、Haemophilus、Lactobacillus、Leptotrichia、Neisseria、Porphyromonas、Prevotella、Rothia、Streptococcus和Veillonella。OTU-PCA分析表明,两组口腔菌群的优势成分存在不确定的差异,但无统计学意义的差异(P>0.05)。此外,两组的口腔菌群多样性趋势相同(P>0.05)。同样,物种注释分析和热图显示,两组口腔唾液菌群组成无显著差异(P>0.05)。乳杆菌一直是Phylume、Class、Order、Family和Genus中的主要菌群,但两组之间的丰度比不同:BM组唾液菌群中乳杆菌的丰度高于BS组,结论BM组和BS组唾液中的优势菌群均为乳杆菌,BM组乳杆菌的丰度高于BS组,说明巴马县人口的长寿可能与乳杆菌有关。关键词:长寿;唾液;DNA,细菌
{"title":"Analysis of difference in oral bacteria flora in saliva among elderly people in longevity zone of Guangxi","authors":"Yan-Chun Qin, Yan-Qiang Huang, H. Tang, Gan-rong Huang, Hong-Yu Wei, Zhenfeng Xie, Gang Lu","doi":"10.3760/CMA.J.ISSN.0254-9026.2020.01.015","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2020.01.015","url":null,"abstract":"Objective \u0000To investigate the bacterial species, characteristics and differences of oral bacteria flora of saliva in the longevous elderly between in Bama county and in Debao county in Guangxi, in order to explore the relationship between longevity and oral salivary bacteria flora in the elderly. \u0000 \u0000 \u0000Methods \u0000The saliva was taken from the longevous elderly in Bama county(BM group)and people aged over 60 years in Debao county(BS group)separately, and the total DNA was extracted.The 16S rDNA-V4 region was amplified by PCR and analyzed by sequencing.The main species and diversity of bacterial colonies were recorded for difference analysis. \u0000 \u0000 \u0000Results \u0000A total of 14 saliva samples were collected from 7 cases in BM group and 7 cases in BS group.A total of 369 OTUs were generated by cluster analysis of 14 samples.At the genus level, the dominant salivary bacteria flora were Ctinomyces, Capnocytophaga, Chryseobacterium, Fusobacterium, Haemophilus, Lactobacillus, Leptotrichia, Neisseria, Porphyromonas, Prevotella, Rothia, Streptococcus, Veillonella in both BM group and BS group.The OTU PCA analysis showed that some evidence for indeterminate differences was found, but statistically significant differences did not exist in the dominant components of oral flora between the two groups(P>0.05). Also, the same tendency toward the diversity(P>0.05)was presented.Similarly, the species annotation analysis and the heat map showed that there were no significant differences(P>0.05)in oral salivary flora composition between the two groups.Lactobacillu was always the prevailing flora in the Phylume, Class, Order, Family and Genus, but the abundance ratio was different between the two groups as following: Lactobacillus abundance in salivary bacteria flora was higher in BM Group than in the BS group, while Mycoplasma abundance was lower in BM Group than in the BS group(P<0.05). \u0000 \u0000 \u0000Conclusions \u0000The dominant salivary bacteria flora is Lactobacillus in both BM and BS group, while, the abundance of Lactobacillus is higher in the BM group than in the BS group, which indicates that the longevity of population in Bama county may be related to Lactobacillus. \u0000 \u0000 \u0000Key words: \u0000Longevity; Saliva; DNA, bacterial","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"39 1","pages":"78-82"},"PeriodicalIF":0.0,"publicationDate":"2020-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41727584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Sacubitril/Valsartan for alleviating chronic heart failure in elderly patients after acute myocardial infarction 舒比利/缬沙坦对老年急性心肌梗死后慢性心力衰竭的缓解作用
Pub Date : 2020-01-14 DOI: 10.3760/CMA.J.ISSN.0254-9026.2020.01.007
Hong Yang, Xiao‐yu Sun, Jing Liu, Yu-Qing Yuan
Objective To evaluate the effect of Sacubitril/Valsartan for alleviating chronic heart failure(CHF)in elderly patients after acute myocardial infarction(AMI). Methods A total of 87 elderly patients with AMI-induced CHF treated in Heze Shili Hospital from October 2017 to August 2018 were enrolled and randomly divided into the experimental group(n=42)and the control group(n=45). All patients were given standard AMI treatments, and patients in the experimental group were given Sacubitril/Valsartan(100 mg bid)while those in the control group received Valsartan(80 mg qd). After a follow-up of 12 months, levels of N-terminal pro-brain natriuretic peptide(NT-proBNP), left ventricular end-diastolic diameter(LVDd), left ventricular ejection fraction(LVEF), rates of rehospitalization for heart failure and all-cause mortality were compared between the two groups. Results Among the 87 patients, 51 patients(58.6%)were male and 36 were female, with an averageage of(67.4±4.0)years.After 12-months of treatment, patients in the experimental group were associated with significantly lower levels of LVDd[(47.86±3.86)mm vs.(50.73±4.39)mm, P<0.05]and NT-proBNP[(793.43±335.43)ng/L vs.(1 068.44±344.46)ng/L, P<0.05]and higher levels of LVEF[(53.74±4.08)% vs.(44.42±7.41)%, P<0.05]than those in the control group.Moreover, the rehospitalization rate for heart failure was markedly higher in the control group than that in the experimental group[15(33.3%)vs.5(11.9%), P<0.05], while the rate of all-cause mortality was similar between the two groups[2(4.8%)vs.3(6.7%), P=0.703]. Conclusions Compared with Valsartan, Sacubitril/Valsartan can reduce the incidence of CHF after AMI, improve left ventricular function, and reduce the rehospitalization rate due to CHF in elderly patients. Key words: Myocardial infarction; Heart failure; Neprilysin
目的评价舒必曲/缬沙坦对老年急性心肌梗死(AMI)后慢性心力衰竭(CHF)的缓解作用。方法将2017年10月至2018年8月在菏泽市十里医院接受治疗的87例老年AMI致CHF患者随机分为实验组(n=42)和对照组(n=45)。所有患者都接受了标准的AMI治疗,实验组患者接受了舒比曲/缬沙坦(100mg bid)治疗,而对照组患者接受缬沙坦(80mg qd)治疗。随访12个月后,比较两组患者的N-末端脑钠素原(NT-proBNP)水平、左心室舒张末期直径(LVDd)、左心室射血分数(LVEF)、心力衰竭再住院率和全因死亡率。结果87例患者中男性51例(58.6%),女性36例,平均年龄(67.4±4.0)年,实验组患者的LVDd水平[(47.86±3.86)mm vs.(50.73±4.39)mm,P<0.05]和NT-proBNP水平[(793.43±335.43)ng/L vs.(1068.44±344.46)ng/L,P<0.05]显著低于对照组,LVEF水平[(53.74±4.08)%vs.(44.42±7.41)%,P<0.05]高于对照组。此外,对照组心力衰竭再次住院率明显高于实验组[15(33.3%)vs.5(11.9%),P<0.05],而两组全因死亡率相似[2(4.8%)vs.3(6.7%),P=0.703],改善左心室功能并降低老年患者因CHF而再次住院的比率。关键词:心肌梗死;心力衰竭;尼泊尔赖氨酸
{"title":"Effect of Sacubitril/Valsartan for alleviating chronic heart failure in elderly patients after acute myocardial infarction","authors":"Hong Yang, Xiao‐yu Sun, Jing Liu, Yu-Qing Yuan","doi":"10.3760/CMA.J.ISSN.0254-9026.2020.01.007","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2020.01.007","url":null,"abstract":"Objective \u0000To evaluate the effect of Sacubitril/Valsartan for alleviating chronic heart failure(CHF)in elderly patients after acute myocardial infarction(AMI). \u0000 \u0000 \u0000Methods \u0000A total of 87 elderly patients with AMI-induced CHF treated in Heze Shili Hospital from October 2017 to August 2018 were enrolled and randomly divided into the experimental group(n=42)and the control group(n=45). All patients were given standard AMI treatments, and patients in the experimental group were given Sacubitril/Valsartan(100 mg bid)while those in the control group received Valsartan(80 mg qd). After a follow-up of 12 months, levels of N-terminal pro-brain natriuretic peptide(NT-proBNP), left ventricular end-diastolic diameter(LVDd), left ventricular ejection fraction(LVEF), rates of rehospitalization for heart failure and all-cause mortality were compared between the two groups. \u0000 \u0000 \u0000Results \u0000Among the 87 patients, 51 patients(58.6%)were male and 36 were female, with an averageage of(67.4±4.0)years.After 12-months of treatment, patients in the experimental group were associated with significantly lower levels of LVDd[(47.86±3.86)mm vs.(50.73±4.39)mm, P<0.05]and NT-proBNP[(793.43±335.43)ng/L vs.(1 068.44±344.46)ng/L, P<0.05]and higher levels of LVEF[(53.74±4.08)% vs.(44.42±7.41)%, P<0.05]than those in the control group.Moreover, the rehospitalization rate for heart failure was markedly higher in the control group than that in the experimental group[15(33.3%)vs.5(11.9%), P<0.05], while the rate of all-cause mortality was similar between the two groups[2(4.8%)vs.3(6.7%), P=0.703]. \u0000 \u0000 \u0000Conclusions \u0000Compared with Valsartan, Sacubitril/Valsartan can reduce the incidence of CHF after AMI, improve left ventricular function, and reduce the rehospitalization rate due to CHF in elderly patients. \u0000 \u0000 \u0000Key words: \u0000Myocardial infarction; Heart failure; Neprilysin","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"39 1","pages":"38-42"},"PeriodicalIF":0.0,"publicationDate":"2020-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47897350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Mechanisms and potential therapeutic targets for coronary collateral growth 冠状动脉侧支生长的机制和潜在的治疗靶点
Pub Date : 2020-01-14 DOI: 10.3760/CMA.J.ISSN.0254-9026.2020.01.019
Mengyang Zhang, J. Fan, Yacong Liu
Induction of coronary collateral circulation, that is, therapeutic angiogenesis, is considered a promising treatment for coronary heart disease.However, coronary collateral growth is a complex process and is related to a variety of factors.Although it has achieved promising outcomes in animal experiments, clinical trials have so far failed to replicate these results.Further studies on the growth mechanisms of coronary collateral circulation are still needed before a feasible clinical treatment strategy becomes available. Key words: Coronary circulation; Collateral circulatio
诱导冠状动脉侧支循环,即治疗性血管生成,被认为是治疗冠心病的一种有前景的方法。然而,冠状动脉侧支生长是一个复杂的过程,与多种因素有关。尽管它在动物实验中取得了有希望的结果,但临床试验迄今未能复制这些结果。在可行的临床治疗策略出现之前,还需要对冠状动脉侧支循环的生长机制进行进一步的研究。关键词:冠状动脉循环;抵押品流通
{"title":"Mechanisms and potential therapeutic targets for coronary collateral growth","authors":"Mengyang Zhang, J. Fan, Yacong Liu","doi":"10.3760/CMA.J.ISSN.0254-9026.2020.01.019","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2020.01.019","url":null,"abstract":"Induction of coronary collateral circulation, that is, therapeutic angiogenesis, is considered a promising treatment for coronary heart disease.However, coronary collateral growth is a complex process and is related to a variety of factors.Although it has achieved promising outcomes in animal experiments, clinical trials have so far failed to replicate these results.Further studies on the growth mechanisms of coronary collateral circulation are still needed before a feasible clinical treatment strategy becomes available. \u0000 \u0000 \u0000Key words: \u0000Coronary circulation; Collateral circulatio","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"39 1","pages":"96-99"},"PeriodicalIF":0.0,"publicationDate":"2020-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48357042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationships between intracranial compartment volumes and clinical symptoms in patients with idiopathic normal pressure hydrocephalus before and after cerebrospinal fluid shunt surgery 特发性常压脑积水患者脑脊液分流术前后颅内隔室容积与临床症状的关系
Pub Date : 2020-01-14 DOI: 10.3760/CMA.J.ISSN.0254-9026.2020.01.010
Wenjie He, Xuhao Fang, Xiaowei Wang, P. Gao, Weiquan Shu, Xing Gao, Jiejiao Zheng, J. Chang, Y. Hua, R. Mao
Objective To investigate the relationships of intracranial compartment volumes with the severity of clinical symptoms before surgery, and the degree of symptom improvement one year after cerebrospinal fluid(CSF)shunt surgery in patients with idiopathic normal pressure hydrocephalus(iNPH). Methods Twenty-one patients meeting the diagnosis criteria of international guidelines of iNPH and undergoing CSF shunt surgery in Department of Neurosurgery in our hospital from 2016 to 2017 were included.All patients underwent brain MRI measurement before surgery, and were evaluated by using 3-meter timed up and go test(TUG), minimum mental state examination(MMSE), idiopathic normal pressure hydrocephalus grading scale(iNPHGS)and modified Rankin scale(mRS)before and one year after CSF shunt procedures.The ventricular volume, brain volume, pericerebral CSF volume, total intracranial volume and Evans' index were measured in the pre-operative imaging of the brain.The following four pre-operative intracranial compartment volumes were calculated: the relative ventricular volume, brain volume ratio, pericerebral CSF volume ratio and the ratio of ventricular volume to pericerebral CSF volume. Results The scores of gait, cognitive function and urinary function were improved after surgery in iNPH patients(all P 0.05). There was no significant difference in intracranial compartment volumes between patients having improvement in mRS, TUG, MMSE and iNPHGS and patients having no improvement one year after surgery in iNPH patients(all P>0.05). Conclusions Patients with iNPH can benefit from CSF shunt surgery and have improvements of clinical symptoms including gait, cognitive function and urinary function.Preoperative intracranial compartment volumes(the relative ventricular volume, brain volume ratio, pericerebral CSF volume ratio and the ratio of ventricular volume to pericerebral CSF volume)and Evans' index have no correlations with the severity of clinical symptoms before surgery, and have no correlations with the degree of symptom improvement one year after surgery in iNPH patients.For this reason, preoperative intracranial compartment volumes and Evans' index cannot be used to predict whether or not CSF shunt surgery can improve specific clinical symptoms. Key words: Hydrocephalus, normal pressure; Cerebral ventricles; Cerebrospinal fluid shunts
目的探讨特发性常压脑积水(iNPH)患者术前颅内隔室容积与临床症状严重程度及脑脊液(CSF)分流术后1年症状改善程度的关系。方法纳入2016年至2017年在我院神经外科接受脑脊液分流术并符合国际iNPH指南诊断标准的21例患者。所有患者在手术前均接受了脑MRI测量,并在脑脊液分流术前和术后一年分别采用3米计时启动试验(TUG)、最低精神状态检查(MMSE)、特发性常压脑积水分级量表(iNPHGS)和改良兰金量表(mRS)进行评估。术前测量脑室容积、脑容积、脑周CSF容积、颅内总容积和Evans指数。计算以下四个术前颅内隔室容积:相对心室容积、脑容积比、脑周CSF容积比和心室容积与脑周CSF体积之比。结果iNPH患者术后步态、认知功能和尿功能评分均有改善(均P<0.05),iNPH患者术后1年无明显改善(均P>0.05)。iNPH患者术前颅内隔室容积(相对心室容积、脑容积比、脑周CSF容积比和心室容积与脑周CSF体积比)和Evans指数与术前临床症状的严重程度无关,与术后一年症状改善程度无关。因此,术前颅内隔室容积和Evans指数不能用来预测CSF分流手术是否能改善特定的临床症状。关键词:脑积水,正常压力;脑室;脑脊液分流器
{"title":"Relationships between intracranial compartment volumes and clinical symptoms in patients with idiopathic normal pressure hydrocephalus before and after cerebrospinal fluid shunt surgery","authors":"Wenjie He, Xuhao Fang, Xiaowei Wang, P. Gao, Weiquan Shu, Xing Gao, Jiejiao Zheng, J. Chang, Y. Hua, R. Mao","doi":"10.3760/CMA.J.ISSN.0254-9026.2020.01.010","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2020.01.010","url":null,"abstract":"Objective \u0000To investigate the relationships of intracranial compartment volumes with the severity of clinical symptoms before surgery, and the degree of symptom improvement one year after cerebrospinal fluid(CSF)shunt surgery in patients with idiopathic normal pressure hydrocephalus(iNPH). \u0000 \u0000 \u0000Methods \u0000Twenty-one patients meeting the diagnosis criteria of international guidelines of iNPH and undergoing CSF shunt surgery in Department of Neurosurgery in our hospital from 2016 to 2017 were included.All patients underwent brain MRI measurement before surgery, and were evaluated by using 3-meter timed up and go test(TUG), minimum mental state examination(MMSE), idiopathic normal pressure hydrocephalus grading scale(iNPHGS)and modified Rankin scale(mRS)before and one year after CSF shunt procedures.The ventricular volume, brain volume, pericerebral CSF volume, total intracranial volume and Evans' index were measured in the pre-operative imaging of the brain.The following four pre-operative intracranial compartment volumes were calculated: the relative ventricular volume, brain volume ratio, pericerebral CSF volume ratio and the ratio of ventricular volume to pericerebral CSF volume. \u0000 \u0000 \u0000Results \u0000The scores of gait, cognitive function and urinary function were improved after surgery in iNPH patients(all P 0.05). There was no significant difference in intracranial compartment volumes between patients having improvement in mRS, TUG, MMSE and iNPHGS and patients having no improvement one year after surgery in iNPH patients(all P>0.05). \u0000 \u0000 \u0000Conclusions \u0000Patients with iNPH can benefit from CSF shunt surgery and have improvements of clinical symptoms including gait, cognitive function and urinary function.Preoperative intracranial compartment volumes(the relative ventricular volume, brain volume ratio, pericerebral CSF volume ratio and the ratio of ventricular volume to pericerebral CSF volume)and Evans' index have no correlations with the severity of clinical symptoms before surgery, and have no correlations with the degree of symptom improvement one year after surgery in iNPH patients.For this reason, preoperative intracranial compartment volumes and Evans' index cannot be used to predict whether or not CSF shunt surgery can improve specific clinical symptoms. \u0000 \u0000 \u0000Key words: \u0000Hydrocephalus, normal pressure; Cerebral ventricles; Cerebrospinal fluid shunts","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"39 1","pages":"51-56"},"PeriodicalIF":0.0,"publicationDate":"2020-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46513571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical significance of the monocyte to high-density lipoprotein cholesterol ratio in the assessment of imperfect ST-segment resolution in elderly patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention 单核细胞/高密度脂蛋白胆固醇比值评价老年急性st段抬高型心肌梗死经皮冠状动脉介入治疗后st段消退不全的临床意义
Pub Date : 2020-01-14 DOI: 10.3760/CMA.J.ISSN.0254-9026.2020.01.006
F. Xu, Xiaodan Cheng, Dongwei Yang
Objective To investigate the clinical significance of the monocyte count/high-density lipoprotein cholesterol ratio(MHR)in evaluating imperfect ST-segment resolution in elderly patients with acute ST-elevation myocardial infarction(STEMI)after percutaneous coronary intervention(PCI). Methods This was a retrospective cohort study.A total of 274 elderly patients with STEMI underwent PCI in our hospital from December 2015 to December 2018 were enrolled.Based on the extent of the ST-segment resolution of the postoperative electrocardiogram, patients were divided into an imperfect ST-segment resolution group(observation group, n=79)and a favorable ST-segment resolution group(control group, n=195). General clinical data were compared between the two groups, and logistic regression equation was used to analyze the association of MHR with ST-segment resolution.Receiver operating characteristic(ROC)curve was performed to assess the predictive value of MHR for imperfect ST-segment resolution. Results Compared with patients in the control group, patients in the observation group were associated with a significantly higher proportion of anterior wall myocardial infarction and heart failure(≥Killip 2), A longer duration of chest pain to balloon expansion, higher levels of creatine kinase isoenzyme, N-terminal pro-brain natriuretic peptide, hypersensitive C-reactive protein, blood sugar, blood uric acid, fibrinogen, triglyceride and mononuclear cell count, and lower levels of high density lipoprotein cholesterol and lymphocyte count(all P<0.05). Meanwhile, there was a significant difference in MHR between the observation group and the control group [(0.75±0.22)vs.(0.48±0.19), t=9.831, P=0.001]. Multivariate Logistic regression analysis showed that MHR was an independent risk factor for imperfect ST-segment resolution(OR=1.950, 95%CI: 1.646-5.430, P=0.003)and ROC curve showed the threshold value of MHR at 0.67, the area under the curve at 0.867, the sensitivity at 79.72%, and the specificity at 79.61%. Conclusions MHR may be an independent risk factor and a good predictive index for imperfect ST-segment resolution in elderly patients with STEMI after PCI. Key words: Monocytes; Lipoproteins HDL; Myocardial infarction
目的探讨单核细胞计数/高密度脂蛋白胆固醇比值(MHR)评价老年急性st段抬高型心肌梗死(STEMI)经皮冠状动脉介入治疗(PCI)后st段不完全分解的临床意义。方法回顾性队列研究。纳入2015年12月至2018年12月在我院行PCI治疗的老年STEMI患者274例。根据术后心电图st段溶解程度将患者分为st段溶解不完全组(观察组,n=79)和st段溶解良好组(对照组,n=195)。比较两组患者一般临床资料,采用logistic回归方程分析MHR与st段分辨率的相关性。采用受试者工作特征(ROC)曲线评估MHR对st段不完全分辨的预测价值。结果与对照组相比,观察组患者前壁心肌梗死和心衰发生率(≥Killip 2)显著增高,胸痛至球囊扩张持续时间较长,肌酸激酶同功酶、n端脑利钠肽前体、超敏c反应蛋白、血糖、血尿酸、纤维蛋白原、甘油三酯和单核细胞计数水平升高。高密度脂蛋白胆固醇和淋巴细胞计数降低(均P<0.05)。观察组与对照组MHR比较差异有统计学意义[(0.75±0.22)比(0.48±0.19),t=9.831, P=0.001]。多因素Logistic回归分析显示,MHR是st段分辨率不全的独立危险因素(OR=1.950, 95%CI: 1.646 ~ 5.430, P=0.003), ROC曲线显示MHR的阈值为0.67,曲线下面积为0.867,敏感性为79.72%,特异性为79.61%。结论MHR可能是老年STEMI患者PCI术后st段消退不全的独立危险因素和较好的预测指标。关键词:单核细胞;脂蛋白高密度脂蛋白;心肌梗死
{"title":"Clinical significance of the monocyte to high-density lipoprotein cholesterol ratio in the assessment of imperfect ST-segment resolution in elderly patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention","authors":"F. Xu, Xiaodan Cheng, Dongwei Yang","doi":"10.3760/CMA.J.ISSN.0254-9026.2020.01.006","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2020.01.006","url":null,"abstract":"Objective \u0000To investigate the clinical significance of the monocyte count/high-density lipoprotein cholesterol ratio(MHR)in evaluating imperfect ST-segment resolution in elderly patients with acute ST-elevation myocardial infarction(STEMI)after percutaneous coronary intervention(PCI). \u0000 \u0000 \u0000Methods \u0000This was a retrospective cohort study.A total of 274 elderly patients with STEMI underwent PCI in our hospital from December 2015 to December 2018 were enrolled.Based on the extent of the ST-segment resolution of the postoperative electrocardiogram, patients were divided into an imperfect ST-segment resolution group(observation group, n=79)and a favorable ST-segment resolution group(control group, n=195). General clinical data were compared between the two groups, and logistic regression equation was used to analyze the association of MHR with ST-segment resolution.Receiver operating characteristic(ROC)curve was performed to assess the predictive value of MHR for imperfect ST-segment resolution. \u0000 \u0000 \u0000Results \u0000Compared with patients in the control group, patients in the observation group were associated with a significantly higher proportion of anterior wall myocardial infarction and heart failure(≥Killip 2), A longer duration of chest pain to balloon expansion, higher levels of creatine kinase isoenzyme, N-terminal pro-brain natriuretic peptide, hypersensitive C-reactive protein, blood sugar, blood uric acid, fibrinogen, triglyceride and mononuclear cell count, and lower levels of high density lipoprotein cholesterol and lymphocyte count(all P<0.05). Meanwhile, there was a significant difference in MHR between the observation group and the control group [(0.75±0.22)vs.(0.48±0.19), t=9.831, P=0.001]. Multivariate Logistic regression analysis showed that MHR was an independent risk factor for imperfect ST-segment resolution(OR=1.950, 95%CI: 1.646-5.430, P=0.003)and ROC curve showed the threshold value of MHR at 0.67, the area under the curve at 0.867, the sensitivity at 79.72%, and the specificity at 79.61%. \u0000 \u0000 \u0000Conclusions \u0000MHR may be an independent risk factor and a good predictive index for imperfect ST-segment resolution in elderly patients with STEMI after PCI. \u0000 \u0000 \u0000Key words: \u0000Monocytes; Lipoproteins HDL; Myocardial infarction","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"39 1","pages":"33-37"},"PeriodicalIF":0.0,"publicationDate":"2020-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43132670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy and safety of Rivaroxaban for elderly patients with thrombotic diseases 利伐沙班治疗老年血栓性疾病患者的疗效和安全性
Pub Date : 2020-01-14 DOI: 10.3760/CMA.J.ISSN.0254-9026.2020.01.008
Sha-sha Sun, Jian Cao, Hongbin Liu, Jiakun Luo, Weihao Xu, Lu Liu, Yanqi Di, X. Zou, Jian-hua Li
Objective To investigate the efficacy and safety of Rivaroxaban for elderly patients with thrombotic diseases. Methods This was a retrospective study.A total of 301 elderly patients taking Rivaroxaban from October 2012 to November 2017 at the Second Medical Center of the Chinese PLA General Hospital were consecutively selected.The ages ranged from 60 to 102 years, with an average age of(86.5±8.4)years.Anticoagulation regimens were developed based on comprehensive evaluation of indications, creatinine clearance, ischemia and bleeding risk.Patients were divided into a Rivaroxaban 2.5-5.0 mg/d group(n=72), a 10.0 mg/d group(n=205), and a 15.0-20.0 mg/d group(n=24). Hepatic function, renal function, and coagulation indexes were measured before and after the administration of Rivaroxaban.Fatal bleeding, cardiovascular deaths, all-cause deaths, non-fatal bleeding and thromboembolic events were recorded during the follow-up period. Results The average dose of Rivaroxaban was(9.3±3.0)mg/d, and the minimum dose was 2.5 mg/d.The average follow-up time was(14.9± 13.9)months and the longest follow-up time was 48 months.One patient had intracranial bleeding.Twenty patients(6.6%)died with a cumulative incidence of 25.2%, three(1.0%)died of cardiac events, and 55.0% died of pneumonia and multiple organ failure.Forty patients(13.3%)had non-fatal hemorrhagic events with a cumulative incidence of 42.4%.Seven patients(2.3%)had thromboembolic events with a cumulative incidence of 16.0%, including 2 cases of non-fatal myocardial infarction, 3 cases of cerebral infarction and 2 cases of deep vein thrombosis.After treatment, levels of prothrombin time and fibrinogen significantly increased while levels of D-dimer significantly deceased(P<0.05). Conclusions Compared with previous reports, low-dose Rivaroxaban is safe and effective for elderly patients with thrombotic diseases.However, the risk of bleeding and ischemia should be comprehensively evaluated, and appropriate doses of Rivaroxaban should be selected individually. Key words: Rivaroxaban; Thromboembolism; Hemorrage
目的探讨利伐沙班治疗老年血栓性疾病的疗效和安全性。方法回顾性研究。连续选取2012年10月至2017年11月在中国人民解放军总医院第二医疗中心接受利伐沙班治疗的老年患者301例。年龄60 ~ 102岁,平均(86.5±8.4)岁。抗凝方案的制定是基于适应症、肌酐清除率、缺血和出血风险的综合评估。将患者分为利伐沙班2.5 ~ 5.0 mg/d组(n=72)、10.0 mg/d组(n=205)和15.0 ~ 20.0 mg/d组(n=24)。应用利伐沙班前后测定肝功能、肾功能、凝血指标。在随访期间记录致命性出血、心血管死亡、全因死亡、非致命性出血和血栓栓塞事件。结果利伐沙班平均给药剂量为(9.3±3.0)mg/d,最小给药剂量为2.5 mg/d。平均随访时间(14.9±13.9)个月,最长随访时间48个月。1例患者颅内出血。20例(6.6%)患者死亡,累计发病率25.2%,3例(1.0%)患者死于心脏事件,55.0%患者死于肺炎和多器官衰竭。40例(13.3%)患者发生非致死性出血事件,累计发生率为42.4%。7例(2.3%)患者发生血栓栓塞事件,累计发生率为16.0%,其中非致死性心肌梗死2例,脑梗死3例,深静脉血栓形成2例。治疗后凝血酶原时间、纤维蛋白原水平显著升高,d -二聚体水平显著降低(P<0.05)。结论与以往报道相比,低剂量利伐沙班治疗老年血栓性疾病安全有效。然而,应综合评估出血和缺血的风险,并单独选择合适的利伐沙班剂量。关键词:利伐沙班;血栓栓塞;Hemorrage
{"title":"The efficacy and safety of Rivaroxaban for elderly patients with thrombotic diseases","authors":"Sha-sha Sun, Jian Cao, Hongbin Liu, Jiakun Luo, Weihao Xu, Lu Liu, Yanqi Di, X. Zou, Jian-hua Li","doi":"10.3760/CMA.J.ISSN.0254-9026.2020.01.008","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2020.01.008","url":null,"abstract":"Objective \u0000To investigate the efficacy and safety of Rivaroxaban for elderly patients with thrombotic diseases. \u0000 \u0000 \u0000Methods \u0000This was a retrospective study.A total of 301 elderly patients taking Rivaroxaban from October 2012 to November 2017 at the Second Medical Center of the Chinese PLA General Hospital were consecutively selected.The ages ranged from 60 to 102 years, with an average age of(86.5±8.4)years.Anticoagulation regimens were developed based on comprehensive evaluation of indications, creatinine clearance, ischemia and bleeding risk.Patients were divided into a Rivaroxaban 2.5-5.0 mg/d group(n=72), a 10.0 mg/d group(n=205), and a 15.0-20.0 mg/d group(n=24). Hepatic function, renal function, and coagulation indexes were measured before and after the administration of Rivaroxaban.Fatal bleeding, cardiovascular deaths, all-cause deaths, non-fatal bleeding and thromboembolic events were recorded during the follow-up period. \u0000 \u0000 \u0000Results \u0000The average dose of Rivaroxaban was(9.3±3.0)mg/d, and the minimum dose was 2.5 mg/d.The average follow-up time was(14.9± 13.9)months and the longest follow-up time was 48 months.One patient had intracranial bleeding.Twenty patients(6.6%)died with a cumulative incidence of 25.2%, three(1.0%)died of cardiac events, and 55.0% died of pneumonia and multiple organ failure.Forty patients(13.3%)had non-fatal hemorrhagic events with a cumulative incidence of 42.4%.Seven patients(2.3%)had thromboembolic events with a cumulative incidence of 16.0%, including 2 cases of non-fatal myocardial infarction, 3 cases of cerebral infarction and 2 cases of deep vein thrombosis.After treatment, levels of prothrombin time and fibrinogen significantly increased while levels of D-dimer significantly deceased(P<0.05). \u0000 \u0000 \u0000Conclusions \u0000Compared with previous reports, low-dose Rivaroxaban is safe and effective for elderly patients with thrombotic diseases.However, the risk of bleeding and ischemia should be comprehensively evaluated, and appropriate doses of Rivaroxaban should be selected individually. \u0000 \u0000 \u0000Key words: \u0000Rivaroxaban; Thromboembolism; Hemorrage","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"39 1","pages":"43-46"},"PeriodicalIF":0.0,"publicationDate":"2020-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45808572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华老年医学杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1